The prevalence of type 2 diabetes increases with age, with an estimated 8.6 million Americans over the age of 60 diagnosed with diabetes, and a growing number at-risk for developing diabetes with age. Our elderly face unique diabetes management challenges. Join host Dr. Steven Edelman and his guest, registered dietitian and Certified Diabetes Educator Janice Baker, as they discuss the unique challenges in caring for our elderly patients with diabetes.
Addressing the Unique Challenges for Elderly Patients with Diabetes
Restart
Resume
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
The prevalence of type 2 diabetes increases with age, with an estimated 8.6 million Americans over the age of 60 diagnosed with diabetes, and a growing number at-risk for developing diabetes with age. Our elderly face unique diabetes management challenges. Join host Dr. Steven Edelman and his guest, registered dietitian and Certified Diabetes Educator Janice Baker, as they discuss the unique challenges in caring for our elderly patients with diabetes.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
CME/CE
Bridging Distances in PAH: Bringing Best Practices to the People Through Telementoring
1.00 credits
<p>Bridging Distances in PAH: Bringing Best Practices to the People Through Telementoring</p>
CME/CE
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
0.25 credits
<p>Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective</p>
MinuteCE®
HF Management for Patients with Comorbid Conditions
0.75 credits
<p>HF Management for Patients with Comorbid Conditions</p>
MinuteCE®
What do we know now that could have changed the history of CETP inhibition?: genetics and biology
0.50 credits
<p>What do we know now that could have changed the history of CETP inhibition?: genetics and biology </p>
MinuteCE®
CETP inhibition: Lessons from two decades of clinical trials
0.50 credits
<p><span data-contrast="none" style="list-style-type: disc;" xml:lang="EN-US">CETP inhibition: Lessons from two decades of clinical trials</span></p>
MinuteCE®
A novel CETP inhibitor to target CV risk reduction: Where could it fit in future lipid management?
0.50 credits
<p><span data-contrast="none" style="list-style-type: disc;" xml:lang="EN-US">A novel CETP inhibitor to target CV risk reduction: Where could it fit in future lipid management?</span></p>
CME/CE Broadcast Replay
Risk Assessment in Pulmonary Hypertension: Practice Trends and Updates
1.00 credits
<p>Risk Assessment in Pulmonary Hypertension: Practice Trends and Updates</p>
CME/CE
Establishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers
1.00 credits
<p>Establishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers</p>
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?